Longwood Fund

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events
  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

Pulmocide Commences a Human RSV Challenge Study with PC786

November 28, 2018

Pulmocide’s PC945 in Phase 1 Study

November 21, 2018

Recros Medica Closes $9M Financing, Strengthens Board

November 14, 2018

Colorescience Launching in the UK

November 14, 2018

Renovia Launches a Multi-Center RCT to Study Next-Generation leva® Pelvic Digital Therapeutic System for UI

November 12, 2018

KalVista Pharmaceuticals Provides Clinical Update on KVD900

November 12, 2018
« Older Entries

Longwood Fund

The Prudential Tower

800 Boylston Street
Suite 1715
Boston, MA, 02199

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

© Longwood Fund. All Rights Reserved